Legislation in Congress, co-sponsored by U.S. Sen. Richard Durbin - D-IL - could expand treatment choices for people with opioid use disorder.

Current federal regulations mandate that people battling addictions use government-approved treatment programs to receive methadone - a drug that curbs opioid cravings.

Senate Bill 644 would expand access through board-certified addiction specialists, who could prescribe methadone in a clinic or doctor's office.

Lindsey Vuolo - vice president of health law and policy at the nonprofit Partnership to End Addiction - said the measure would remove hardships for people who need help.

"The fact that methadone can be prescribed for pain without these restrictions really demonstrates that there isn't medical justification for these types of restrictions," said Vuolo. "And so, it's really crucial to make effective treatment low barrier - or ideally, no barrier - so that people who are in need of these medications can access them without undue restrictions."

Opponents of expanding methadone access have concerns about possible misuse, or that the drug could be distributed or sold illegally.

The bill is in the Senate Committee on Health, Education, Labor, and Pensions, and has been there since February. Nearly 3,300 people died from opioid overdoses in Illinois in 2022.

Under the current restrictions, the government-approved programs are the only option for people getting methadone treatment.

Vuolo pointed out that there aren't enough of these programs, and people receiving the treatment must undergo counseling - which can create even more hurdles to getting care.

"People have difficulty using their insurance to access care and can't afford to pay for the cost out of pocket, and lack of access to providers," said Vuolo. "There's a workforce shortage, so there aren't enough trained providers who are able to provide treatment for opioid use disorder and substance use disorder. Behavioral health in general, there's also lack of mental health providers."

The Illinois Department of Public Health says in 2022, the state's mortality rate from opioid use was 26 deaths per 100-thousand residents.

CORRECTION: The number of traffic fatalities in 2024 in Tennessee represents all traffic deaths, not just those that were alcohol-related. (8:18 a.m. MDT, Apr. 10, 2025)

Lebanon, Tenn., is one of more than 90 cities across the country taking part in Saturday's "Walk Like MADD," a five-kilometer event to help prevent impaired driving.

In 2022, alcohol-impaired driving claimed 364 lives in Tennessee.

Norris Skelley, chairman of the public policy committee for Mothers Against Drunk Driving-Tennessee, said his family became victims of impaired driving three decades ago. He noted 364 lives lost is fewer than in some years, but still indicates a crisis.

"The last two years before that, where both of those years in Tennessee, there were over 400 fatalities in alcohol-related traffic crashes," Skelley reported. "From 2019 to 2023, fatalities rose over 36% in Tennessee and 35% nationwide."

Last year saw more than 1,200 traffic fatalities in Tennessee.

State law imposes harsh penalties for driving under the influence, with first-time offenders facing jail, fines, and license suspension and repeat offenders facing longer jail sentences.

Skelley pointed out they are seeking volunteers for their outreach programs to speak in schools and to other groups about the risks associated with alcohol and drug use. He added raising public awareness is a key strategy for reducing DUIs in the state.

"It happens every day, every 78 seconds, somewhere in this country, someone is injured or killed in an alcohol-related traffic crash," Skelley emphasized. "I think education and public awareness is one of the best things we can do."

He noted volunteers have a chance to share their powerful personal stories of loss, survival and resilience.

Tracia Jungkurth volunteers with the group. Her eight-year-old son, Christopher and his father, Joseph, lost their lives in a drunken driving crash in 1996. Tracia and another son were injured but survived. She will be part of Saturday's walk.

"We will not forget, because there are generations coming behind us that we've got to stand up," Jungkurth stressed. "Because if we don't keep the roads safe, history is going to repeat itself. So that's our goal, is to educate. And prevention and safety."

As a therapist, Jungkurth turned personal pain into purpose by writing a book and founding Christopher Ministries. As DUI crashes rise in Tennessee, she urged people to drive sober and take highway safety seriously.

"The walk is one avenue to show support for the people that are gone," Jungkurth observed. "But I want Tennesseans, as I want all people, to realize that this is preventable and that we, as human beings, need to be responsible for our actions."

She emphasizes MADD's commitment to educating young people in particular about how early drug or alcohol use can negatively affect brain development and judgment.


get more stories like this via email

The Kentucky Board of Medical Licensure recently proposed new changes to regulations around the prescribing and dispensing of buprenorphine, also known by its brand name Suboxone, a Food and Drug Administration approved medication used to treat opioid-use disorder.

Experts say the changes would increase barriers for people who rely on it to keep their lives stable.

Michelle Lofwall is a professor in the Departments of Behavioral Science and Psychiatry at the University of Kentucky. She said the stricter rules send a discouraging message to people in recovery.

"And we know," said Lofwall, "low-barrier care, where patients can really get access to the medication and they can add on what's needed when they're not doing well, is really important."

The new regulations would limit doses patients can receive, mandate participation in counseling services, and require frequent drug testing, among other changes.

Critics of expanding access to buprenorphine, classified as a schedule III substance, argue the drug itself is an opioid that people can become addicted to - and don't address the root causes of substance-use disorders.

The board did not respond to an email request for comment for this story.

Lofwall pointed to the numerous reasons why requiring regular counseling and drug testing can prevent people from being able to access the medication they need.

The new rules would require clinicians see patients using buprenorphine every ten days, or at two-week intervals, in the first few months - and then every few months after two years of treatment.

"A lot of people have jobs that don't let them take off from work to come every week," said Lofwall. "They can be discriminated against because, all of a sudden, they're late, or they just don't have the benefits of a job that allows sick days."

Lofwall said she's confused by the board's actions, given the research showing significant declines in overdose deaths among people taking buprenorphine.

"The Kentucky Board of Medical Licensure just really has had a lack of transparency, I think," said Lofwall, "about the rationale for some of these changes."

According to the Centers for Disease Control and Prevention, in 2023 Kentucky ranked among the top five states for buprenorphine dispensing rates nationwide, along with West Virginia, Vermont and Maine.

Support for this reporting was provided by The Pew Charitable Trusts.




get more stories like this via email

The incidence of drug overdose is decreasing in Indiana and one reason could be the efforts of an organization offering free training to anyone willing to help someone struggling with addiction.

Indianapolis-based Overdose Lifeline works to address the basic needs of families, individuals and communities, showing them how to administer the overdose reversal drug naloxone, or Narcan.

Justin Phillips, founder and CEO of the Overdose Lifeline, explained naloxone can reverse the effects of fentanyl, currently the most prevalent synthetic opioid in the drug supply.

"We want to make people understand opioids and the class and family of opioids," Phillips emphasized. "Then we talk about stigma and harm reduction, and we give people the signs and symptoms of an overdose, and then we provide them with free overdose reversal kits."

She pointed out with proper training, someone can be better suited to reverse an overdose than administer CPR. The training lasts about an hour. In the second quarter of last year, the Marion County Public Health Department reported 124 overdose deaths. It said 56 happened at a residence and 28 at a hospital, 25% fewer than the same time in the previous year.

Phillips noted anyone may know someone who is struggling with addiction. But conversations about drug use and overdoses can be uncomfortable, which she argued reinforces the need for training.

"Sometimes, we're not as willing to go to a pharmacy to acquire Naloxone or talk to our doctor," Phillips acknowledged. "Which is why we do these community events and we make it available, easily accessed in the community, so that you can avoid some of that stigma and judgment."

She added Overdose Lifeline also partners with CareSource for a free program to support Indiana school nurses to implement a naloxone Emergency Preparedness and Response Plan in schools. The program provides free naloxone, emergency medication boxes and staff training.


get more stories like this via email